Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$108.4
Market cap
$21.58B
P/E Ratio
20.57
Dividend/share
$0.96
EPS
$5.27
Enterprise value
$27.46B
Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of
Highlights
The EPS has soared by 133% YoY and by 9% from the previous quarter
The net income has surged by 128% year-on-year and by 9% since the previous quarter
ZBH's quick ratio is down by 28% YoY but it is up by 12% QoQ
The debt has increased by 18% year-on-year and by 11% since the previous quarter
ZBH's equity is down by 2.9% since the previous quarter
Key stats
What are the main financial stats of ZBH
Market
Valuations
Earnings
Shares outstanding
199.07M
Market cap
$21.58B
Enterprise value
$27.46B
Price to earnings (P/E)
20.57
Price to book (P/B)
1.78
Price to sales (P/S)
2.89
EV/EBIT
22.2
EV/EBITDA
12.42
EV/Sales
3.62
Revenue
$7.6B
EBIT
$1.24B
EBITDA
$2.21B
Free cash flow
$1.1B
Per share
Balance sheet
Liquidity
EPS
$5.27
Free cash flow per share
$5.43
Book value per share
$60.76
Revenue per share
$37.55
TBVPS
$40.25
Total assets
$21.72B
Total liabilities
$9.34B
Debt
$6.45B
Equity
$12.37B
Working capital
$1.29B
Debt to equity
0.52
Current ratio
1.36
Quick ratio
0.57
Net debt/EBITDA
2.66
Margins
Efficiency
Dividend
EBITDA margin
29.1%
Gross margin
71.8%
Net margin
14.3%
Operating margin
16.5%
Return on assets
5%
Return on equity
8.6%
Return on invested capital
12%
Return on capital employed
6.8%
Return on sales
16.3%
Dividend yield
0.89%
DPS
$0.96
Payout ratio
18.2%
ZBH stock price
How has the Zimmer Biomet Holdings stock price performed over time
Intraday
-0.8%
1 week
-0.41%
1 month
3.04%
1 year
-3.99%
YTD
-10.93%
QTD
0.42%
Financial performance
How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.6B
Gross profit
$5.45B
Operating income
$1.25B
Net income
$1.08B
Gross margin
71.8%
Net margin
14.3%
The net income has surged by 128% year-on-year and by 9% since the previous quarter
The net margin has surged by 120% year-on-year and by 8% since the previous quarter
Zimmer Biomet Holdings's operating income has increased by 40% YoY
Zimmer Biomet Holdings's operating margin has increased by 34% YoY
Growth
What is Zimmer Biomet Holdings's growth rate over time
Valuation
What is Zimmer Biomet Holdings stock price valuation
P/E
20.57
P/B
1.78
P/S
2.89
EV/EBIT
22.2
EV/EBITDA
12.42
EV/Sales
3.62
The EPS has soared by 133% YoY and by 9% from the previous quarter
ZBH's P/E is 76% lower than its 5-year quarterly average of 86.4 and 15% lower than its last 4 quarters average of 24.1
The stock's P/B is 19% below its 5-year quarterly average of 2.2 and 6% below its last 4 quarters average of 1.9
ZBH's equity is down by 2.9% since the previous quarter
ZBH's price to sales (P/S) is 26% lower than its 5-year quarterly average of 3.9 and 10% lower than its last 4 quarters average of 3.2
The revenue has grown by 4.3% YoY
Efficiency
How efficient is Zimmer Biomet Holdings business performance
The ROA has soared by 127% YoY and by 6% from the previous quarter
Zimmer Biomet Holdings's return on equity has surged by 121% YoY and by 9% QoQ
The ROIC has increased by 41% YoY
The ROS has grown by 31% YoY
Dividends
What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.89%
Payout ratio
18.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Zimmer Biomet Holdings financials performed over time
The total assets is 133% higher than the total liabilities
The current ratio has contracted by 36% YoY but it has grown by 5% from the previous quarter
ZBH's quick ratio is down by 28% YoY but it is up by 12% QoQ
The debt is 48% smaller than the equity
The debt has increased by 18% year-on-year and by 11% since the previous quarter
The debt to equity has grown by 18% year-on-year and by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.